Published on FierceBiotech (http://www.fiercebiotech.com)

Bystolic - 2007 FDA approvals

By maureen
Created Jan 22 2008 - 3:03pm

Drug: Bystolic (nebivolol)
Indication: Hypertension
Company: Forest Laboratories and Mylan
Approval Date: Decembe 18, 2007

Scoop: Bystolic is the 19th approved beta blocker available in the U.S. The drug's developers say it has "placebo-like" side effects, making compliance easier for patients with high blood pressure.

More News:
New "me-too" beta blocker dissed by experts. Report [1]

Previous: Kuvan [2]Index [3]Next: Voluven [4]
Source URL: http://www.fiercebiotech.com/special-reports/bystolic-2007-fda-approvals

Links:
[1] http://www.fiercebiotech.com/story/new-me-too-beta-blocker-dissed-experts/2007-12-19
[2] http://www.fiercebiotech.com/special-reports/kuvan-2007-fda-approvals
[3] http://www.fiercebiotech.com/special-reports/2007-fda-approvals
[4] http://www.fiercebiotech.com/special-reports/voluven-2007-fda-approvals